Achieving UHC depends on quality diagnosis that allows everyone to be linked to the care they need. But too often, fit-for-purpose diagnostics are not available, or affordable, where and when they are required.

Ensuring quality and equality in diagnostic access is a global health priority, and the recent introduction of the Essential Diagnostics List affords the community an unprecedented opportunity.

Join us for this dynamic session, where a globally renowned faculty including governments, implementers and funders will discuss why and how diagnostics are one of the most important – yet often overlooked – enablers of UHC.

Organised jointly with the Foundation for Innovative New Diagnostics andMcGill Global Health Programs